Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 1

Status

Recruiting 139Completed 77Unknown 53Not yet recruiting 36Terminated 17Active not recruiting 16Withdrawn 4Suspended 2

Sponsor Class

OTHER 17INDUSTRY 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Breast 1

Conditions

Leukemia 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Paclitaxel 31Cyclophosphamide 30Cisplatin 29Bevacizumab 28Carboplatin 27Fluorouracil 24pembrolizumab 21Nivolumab 21Leucovorin 20Rituximab 19avelumab 18Gemcitabine 18Docetaxel 18Dexamethasone 18Capecitabine 17ALT-803 15130-nm albumin-bound paclitaxel 14Oxaliplatin 12Cetuximab 12fludarabine 11Ipilimumab 11venetoclax 10atezolizumab 10Radiosurgery 10Radiotherapy 9Pemetrexed 9Omacor 9Lenalidomide 9Bendamustine Hydrochloride 9yeast-CEA vaccine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × INDUSTRY × Injections × Clear all
NCT06545617 2026-01-07

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Bio-Thera Solutions

Phase 1/2 Withdrawn
Gynecologic

Fallopian Tube Neoplasms

NCT05634954 2025-10-23

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

GE Healthcare

Phase 1 Withdrawn
Breast

Breast Neoplasms

NCT00112060 2014-03-31

A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Spectrum Pharmaceuticals, Inc

Phase 1/2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00129558 2013-12-04

A Study to Evaluate PT-523 in Patients With Refractory Leukemia

Spectrum Pharmaceuticals, Inc

Phase 1/2 Withdrawn
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡